Nuclear factor-erythroid 2-related factor 3 (NRF3) is low expressed in colorectal cancer and its down-regulation promotes colorectal cancer malignance through activating EGFR and p38/MAPK.

作者: Zigang Dong , Shan Zhou , Shan Zhou , Yuejin Li , Zhenlin Zhang

DOI:

关键词: CarcinogenesisApoptosisActivating transcription factorProtein kinase BEpidermal growth factor receptorCancer researchCellTranscription factorCell growthChemistry

摘要: Nuclear factor-erythroid 2-related factor 3 (NRF3), a nuclear transcription factor, has been implicated in various cellular processes including carcinogenesis. However, mechanisms underlying its regulation carcinogenesis are unclear. Herein, we found that NRF3 is lowly expressed colorectal cancer (CRC) tissues and cells, low-expressions CRC tissue samples associated with poor patient outcomes. Nrf3-knockdown increased cell growth, colony formation, motility invasion, Nrf3-knockin dramatically decreased growth formation. Mechanistically, apoptosis arrested G2/M stage. was to be reversely epidermal receptor (EGFR) p38. Strikingly, phosphorylated-EGFR at Tyrosine845 (pEGFR Tyr845) phosphorylated-p38 Threonine180/Tyrosine182 (p-p38 Thr180/Tyr182) expressions, pEGFR Tyr845 p-p38 Thr180/Tyr182. Moreover, regulated EGFR p38 down-stream molecules, protein kinase B (AKT), activating (ATF) 2, C/EBP homologous (CHOP) expressions. loss-increased through confirmed nude mice. Collectively, NRF3-loss increases phosphorylation activation, enhances proliferation decreases apoptosis, finally promotes malignance.

参考文章(70)
Alissa K. Greenberg, Sharmila Basu, Jing Hu, Ting-an Yie, Kam Meng Tchou-Wong, William N. Rom, Theodore C. Lee, Selective p38 Activation in Human Non–Small Cell Lung Cancer American Journal of Respiratory Cell and Molecular Biology. ,vol. 26, pp. 558- 564 ,(2002) , 10.1165/AJRCMB.26.5.4689
Kelly Lien, Scott Berry, Yoo-Joung Ko, Kelvin KW Chan, The use of EGFR inhibitors in colorectal cancer: is it clinically efficacious and cost-effective? Expert Review of Pharmacoeconomics & Outcomes Research. ,vol. 15, pp. 81- 100 ,(2015) , 10.1586/14737167.2015.982100
Federica Madia, Valentina Grossi, Alessia Peserico, Cristiano Simone, Updates from the Intestinal Front Line: Autophagic Weapons against Inflammation and Cancer Cells. ,vol. 1, pp. 535- 557 ,(2012) , 10.3390/CELLS1030535
L. D. Wood, D. W. Parsons, S. Jones, J. Lin, T. Sjoblom, R. J. Leary, D. Shen, S. M. Boca, T. Barber, J. Ptak, N. Silliman, S. Szabo, Z. Dezso, V. Ustyanksky, T. Nikolskaya, Y. Nikolsky, R. Karchin, P. A. Wilson, J. S. Kaminker, Z. Zhang, R. Croshaw, J. Willis, D. Dawson, M. Shipitsin, J. K. V. Willson, S. Sukumar, K. Polyak, B. H. Park, C. L. Pethiyagoda, P. V. K. Pant, D. G. Ballinger, A. B. Sparks, J. Hartigan, D. R. Smith, E. Suh, N. Papadopoulos, P. Buckhaults, S. D. Markowitz, G. Parmigiani, K. W. Kinzler, V. E. Velculescu, B. Vogelstein, Genomic landscapes of human breast and colorectal cancers Science. ,vol. 318, pp. 1108- 1113 ,(2008) , 10.1126/SCIENCE.1145720
Christopher Greenman, Philip Stephens, Raffaella Smith, Gillian L. Dalgliesh, Christopher Hunter, Graham Bignell, Helen Davies, Jon Teague, Adam Butler, Claire Stevens, Sarah Edkins, Sarah O’Meara, Imre Vastrik, Esther E. Schmidt, Tim Avis, Syd Barthorpe, Gurpreet Bhamra, Gemma Buck, Bhudipa Choudhury, Jody Clements, Jennifer Cole, Ed Dicks, Simon Forbes, Kris Gray, Kelly Halliday, Rachel Harrison, Katy Hills, Jon Hinton, Andy Jenkinson, David Jones, Andy Menzies, Tatiana Mironenko, Janet Perry, Keiran Raine, Dave Richardson, Rebecca Shepherd, Alexandra Small, Calli Tofts, Jennifer Varian, Tony Webb, Sofie West, Sara Widaa, Andy Yates, Daniel P. Cahill, David N. Louis, Peter Goldstraw, Andrew G. Nicholson, Francis Brasseur, Leendert Looijenga, Barbara L. Weber, Yoke-Eng Chiew, Anna deFazio, Mel F. Greaves, Anthony R. Green, Peter Campbell, Ewan Birney, Douglas F. Easton, Georgia Chenevix-Trench, Min-Han Tan, Sok Kean Khoo, Bin Tean Teh, Siu Tsan Yuen, Suet Yi Leung, Richard Wooster, P. Andrew Futreal, Michael R. Stratton, Patterns of somatic mutation in human cancer genomes Nature. ,vol. 446, pp. 153- 158 ,(2007) , 10.1038/NATURE05610
Akira Kobayashi, Etsuro Ito, Tsutomu Toki, Keiji Kogame, Shinichiro Takahashi, Kazuhiko Igarashi, Norio Hayashi, Masayuki Yamamoto, Molecular cloning and functional characterization of a new Cap'n' collar family transcription factor Nrf3. Journal of Biological Chemistry. ,vol. 274, pp. 6443- 6452 ,(1999) , 10.1074/JBC.274.10.6443
Ruo–Yu Wang, Lei Chen, Hai–Yang Chen, Liang Hu, Liang Li, Han–Yong Sun, Feng Jiang, Jing Zhao, Gao–Mi–Yang Liu, Jing Tang, Cai–Yang Chen, Ying–Cheng Yang, Yan–Xin Chang, Hui Liu, Jin Zhang, Yuan Yang, Gang Huang, Feng Shen, Meng–Chao Wu, Wei–Ping Zhou, Hong–Yang Wang, MUC15 inhibits dimerization of EGFR and PI3K-AKT signaling and is associated with aggressive hepatocellular carcinomas in patients. Gastroenterology. ,vol. 145, pp. 1436- 1448 ,(2013) , 10.1053/J.GASTRO.2013.08.009
Grégory Chevillard, Volker Blank, NFE2L3 (NRF3): the Cinderella of the Cap'n'Collar transcription factors. Cellular and Molecular Life Sciences. ,vol. 68, pp. 3337- 3348 ,(2011) , 10.1007/S00018-011-0747-X
Hui Zhou, Yong-Hao Xu, Can Tan, Xin Zhang, Ya Cao, Fa-Qing Tang, Chao-Jun Duan, Da-Mao Huang, Wei-Wei Wang, Chun-Lei Xie, Jing-Jing Meng, Lei Wang, Hai-Ying Jiang, De-Yun Feng, Shang-Hui Wu, Huan-Hua Gu, Mo-Yu Li, Fu-Liang Deng, Zhi-Jun Gong, HSP70 and mucin 5B: novel protein targets of N,N'-dinitrosopiperazine-induced nasopharyngeal tumorigenesis. Cancer Science. ,vol. 100, pp. 216- 224 ,(2009) , 10.1111/J.1349-7006.2008.01028.X